| Current Price | $33.52 | Mkt Cap | $1.6B |
|---|---|---|---|
| Open | $34.39 | P/E Ratio | -118.57 |
| Prev. Close | $33.52 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $33.12 - $34.39 | Volume | 397,815 |
| 52-Wk Range | $17.30 - $39.90 | Avg. Daily Vol. | 360,239 |
The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.
| Current Price | $33.52 | Mkt Cap | $1.6B |
|---|---|---|---|
| Open | $34.39 | P/E Ratio | -118.57 |
| Prev. Close | $33.52 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $33.12 - $34.39 | Volume | 397,815 |
| 52-Wk Range | $17.30 - $39.90 | Avg. Daily Vol. | 360,239 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about VCEL.
Recs
TMFSecurity
(93.06)
Submitted: 11/16/2021 10:02:15 AM :
Start Price:
$41.67
NASDAQ:VCEL Score:
+11.17
10000000146
Recs
Lakired
(< 20)
Submitted: 9/22/2017 6:44:57 PM :
Start Price:
$3.70
NASDAQ:VCEL Score:
+728.27
VCEL is a buy on the strength of its growing MACI pipeline alone, but an extremely strong buy with two catalysts shortly upcoming. A licensing agreement with ICT to bring VCEL's innovations to the Chinese (and greater Asian) market will be processed in the very near future resulting in an influx of cash. The second catalyst is an anticipated green light from the FDA for accelerated approval of ixCELL. I got in at 3.6, but even at (or just under) 5 (and likely into the 6s) this is still a phenomenal investment with growth potential into the teens by 2018.
Recs
denniscerny
(< 20)
Submitted: 5/15/2017 9:36:01 AM :
Start Price:
$2.65
NASDAQ:VCEL Score:
+1,081.75
Strong pipeline and positive developments.
Find the members with the highest scoring picks in VCEL.
zzlangerhans (99.95) Score: +1,178.67
The Score Leader is the player with the highest score across all their picks in VCEL.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| denniscerny | < 20 | 5/15/2017 |
|
5Y | $2.65 | +1,159.92% | +78.17% | +1,081.75 | 1 Comment | |
| zzlangerhans | 99.95 | 3/22/2017 |
|
1Y | $2.65 | +1,158.49% | +82.58% | +1,075.91 | 0 Comment | |
| Under5 | 56.94 |
|
|
5Y | $2.75 | +1,112.73% | +81.37% | +1,031.36 | 0 Comment | |
| jimbospix | 71.53 | 3/3/2014 |
|
5Y | $3.34 | +898.50% | +131.36% | +767.15 | 0 Comment | |
| Lakired | < 20 | 8/15/2017 |
|
5Y | $3.70 | +801.35% | +73.08% | +728.27 | 1 Comment | |
| ValueHunter09 | 23.95 | 8/18/2014 |
|
5Y | $3.61 | +823.82% | +116.60% | +707.22 | 0 Comment | |
| Ado69 | < 20 | 3/17/2014 |
|
5Y | $3.60 | +826.39% | +130.34% | +696.05 | 0 Comment | |
| showmejp | 76.54 | 11/12/2013 |
|
5Y | $3.66 | +811.20% | +141.60% | +669.61 | 0 Comment | |
| samdeva | 43.73 | 3/11/2014 |
|
5Y | $3.91 | +752.94% | +126.85% | +626.09 | 0 Comment | |
| ajk0928 | < 20 | 3/11/2016 |
|
5Y | $4.23 | +688.42% | +112.40% | +576.01 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
